PubMed:9023548 / 314-463
Annnotations
Glycan-Motif
{"project":"Glycan-Motif","denotations":[{"id":"T2","span":{"begin":41,"end":55},"obj":"https://glytoucan.org/Structures/Glycans/G00054MO"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos600-Glycan-Motif-Structure
{"project":"GlyCosmos600-Glycan-Motif-Structure","denotations":[{"id":"T2","span":{"begin":41,"end":55},"obj":"https://glytoucan.org/Structures/Glycans/G00054MO"},{"id":"T3","span":{"begin":48,"end":55},"obj":"https://glytoucan.org/Structures/Glycans/G01187XC"},{"id":"T4","span":{"begin":48,"end":55},"obj":"https://glytoucan.org/Structures/Glycans/G00051MO"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
Inflammaging
{"project":"Inflammaging","denotations":[{"id":"T3","span":{"begin":0,"end":149},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":149},"obj":"Sentence"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos6-Glycan-Motif-Image
{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T2","span":{"begin":41,"end":55},"obj":"Glycan_Motif"},{"id":"T3","span":{"begin":48,"end":55},"obj":"Glycan_Motif"}],"attributes":[{"id":"A2","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO"},{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G01187XC"},{"id":"A4","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00051MO"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":149},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":149},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos6-Glycan-Motif-Structure
{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T2","span":{"begin":41,"end":55},"obj":"https://glytoucan.org/Structures/Glycans/G00054MO"},{"id":"T3","span":{"begin":48,"end":55},"obj":"https://glytoucan.org/Structures/Glycans/G00051MO"},{"id":"T4","span":{"begin":48,"end":55},"obj":"https://glytoucan.org/Structures/Glycans/G01187XC"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
Glycosmos6-GlycoEpitope
{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":41,"end":55},"obj":"http://www.glycoepitope.jp/epitopes/EP0012"},{"id":"T2","span":{"begin":48,"end":55},"obj":"http://www.glycoepitope.jp/epitopes/EP0011"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T15","span":{"begin":94,"end":108},"obj":"FMAID:263009"},{"id":"_T16","span":{"begin":94,"end":108},"obj":"FMAID:263010"},{"id":"_T17","span":{"begin":97,"end":108},"obj":"FMAID:62870"},{"id":"_T18","span":{"begin":97,"end":108},"obj":"FMAID:167176"},{"id":"_T19","span":{"begin":97,"end":108},"obj":"FMAID:167173"},{"id":"_T20","span":{"begin":97,"end":108},"obj":"FMAID:167163"},{"id":"_T21","span":{"begin":97,"end":108},"obj":"FMAID:167171"},{"id":"_T22","span":{"begin":97,"end":108},"obj":"FMAID:167174"},{"id":"_T23","span":{"begin":97,"end":108},"obj":"FMAID:62869"},{"id":"_T24","span":{"begin":97,"end":108},"obj":"FMAID:62863"},{"id":"_T25","span":{"begin":112,"end":123},"obj":"FMAID:63916"},{"id":"_T26","span":{"begin":112,"end":123},"obj":"FMAID:162384"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T4","span":{"begin":41,"end":47},"obj":"http://purl.obolibrary.org/obo/GO_0097503"},{"id":"T6","span":{"begin":136,"end":148},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"T1","span":{"begin":112,"end":123},"obj":"http://purl.obolibrary.org/obo/UBERON_0001986"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos600-GlycoEpitope
{"project":"GlyCosmos600-GlycoEpitope","denotations":[{"id":"PD-GlycoEpitope-B_T1","span":{"begin":41,"end":55},"obj":"http://www.glycoepitope.jp/epitopes/EP0012"},{"id":"PD-GlycoEpitope-B_T2","span":{"begin":48,"end":55},"obj":"http://www.glycoepitope.jp/epitopes/EP0011"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos600-FMA
{"project":"GlyCosmos600-FMA","denotations":[{"id":"T6","span":{"begin":97,"end":108},"obj":"Body_part"},{"id":"T7","span":{"begin":112,"end":123},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma63916"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos600-GlycoGenes2
{"project":"GlyCosmos600-GlycoGenes2","denotations":[{"id":"T1","span":{"begin":48,"end":55},"obj":"https://acgg.asia/db/ggdb/info/gg003"},{"id":"T2","span":{"begin":48,"end":55},"obj":"https://acgg.asia/db/ggdb/info/gg004"},{"id":"T3","span":{"begin":48,"end":55},"obj":"https://acgg.asia/db/ggdb/info/gg005"},{"id":"T4","span":{"begin":48,"end":55},"obj":"https://acgg.asia/db/ggdb/info/gg006"},{"id":"T5","span":{"begin":48,"end":55},"obj":"https://acgg.asia/db/ggdb/info/gg007"},{"id":"T6","span":{"begin":48,"end":55},"obj":"https://acgg.asia/db/ggdb/info/gg008"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
pubmed-enju-pas
{"project":"pubmed-enju-pas","denotations":[{"id":"EnjuParser_T47","span":{"begin":0,"end":2},"obj":"PRP"},{"id":"EnjuParser_T48","span":{"begin":3,"end":7},"obj":"VBP"},{"id":"EnjuParser_T49","span":{"begin":8,"end":13},"obj":"VBN"},{"id":"EnjuParser_T50","span":{"begin":14,"end":18},"obj":"IN"},{"id":"EnjuParser_T51","span":{"begin":19,"end":28},"obj":"JJ"},{"id":"EnjuParser_T52","span":{"begin":29,"end":40},"obj":"JJ"},{"id":"EnjuParser_T53","span":{"begin":41,"end":47},"obj":"NN"},{"id":"EnjuParser_T54","span":{"begin":48,"end":53},"obj":"NNP"},{"id":"EnjuParser_T55","span":{"begin":54,"end":55},"obj":"NN"},{"id":"EnjuParser_T56","span":{"begin":56,"end":63},"obj":"NNS"},{"id":"EnjuParser_T57","span":{"begin":64,"end":71},"obj":"VBP"},{"id":"EnjuParser_T58","span":{"begin":72,"end":80},"obj":"RB"},{"id":"EnjuParser_T59","span":{"begin":81,"end":84},"obj":"DT"},{"id":"EnjuParser_T60","span":{"begin":85,"end":93},"obj":"NN"},{"id":"EnjuParser_T61","span":{"begin":94,"end":96},"obj":"IN"},{"id":"EnjuParser_T62","span":{"begin":97,"end":108},"obj":"NNS"},{"id":"EnjuParser_T63","span":{"begin":109,"end":111},"obj":"TO"},{"id":"EnjuParser_T64","span":{"begin":112,"end":123},"obj":"NN"},{"id":"EnjuParser_T65","span":{"begin":124,"end":126},"obj":"IN"},{"id":"EnjuParser_T66","span":{"begin":127,"end":132},"obj":"NNS"},{"id":"EnjuParser_T67","span":{"begin":133,"end":135},"obj":"IN"},{"id":"EnjuParser_T68","span":{"begin":136,"end":148},"obj":"NN"}],"relations":[{"id":"EnjuParser_R45","pred":"arg1Of","subj":"EnjuParser_T47","obj":"EnjuParser_T48"},{"id":"EnjuParser_R46","pred":"arg2Of","subj":"EnjuParser_T49","obj":"EnjuParser_T48"},{"id":"EnjuParser_R47","pred":"arg1Of","subj":"EnjuParser_T47","obj":"EnjuParser_T49"},{"id":"EnjuParser_R48","pred":"arg2Of","subj":"EnjuParser_T57","obj":"EnjuParser_T49"},{"id":"EnjuParser_R49","pred":"arg1Of","subj":"EnjuParser_T57","obj":"EnjuParser_T50"},{"id":"EnjuParser_R50","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T51"},{"id":"EnjuParser_R51","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T52"},{"id":"EnjuParser_R52","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T53"},{"id":"EnjuParser_R53","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T54"},{"id":"EnjuParser_R54","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T55"},{"id":"EnjuParser_R55","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T57"},{"id":"EnjuParser_R56","pred":"arg2Of","subj":"EnjuParser_T60","obj":"EnjuParser_T57"},{"id":"EnjuParser_R57","pred":"arg1Of","subj":"EnjuParser_T57","obj":"EnjuParser_T58"},{"id":"EnjuParser_R58","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T59"},{"id":"EnjuParser_R59","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T61"},{"id":"EnjuParser_R60","pred":"arg2Of","subj":"EnjuParser_T62","obj":"EnjuParser_T61"},{"id":"EnjuParser_R61","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T63"},{"id":"EnjuParser_R62","pred":"arg2Of","subj":"EnjuParser_T64","obj":"EnjuParser_T63"},{"id":"EnjuParser_R63","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T65"},{"id":"EnjuParser_R64","pred":"arg2Of","subj":"EnjuParser_T66","obj":"EnjuParser_T65"},{"id":"EnjuParser_R65","pred":"arg1Of","subj":"EnjuParser_T66","obj":"EnjuParser_T67"},{"id":"EnjuParser_R66","pred":"arg2Of","subj":"EnjuParser_T68","obj":"EnjuParser_T67"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlycoBiology-Motifs
{"project":"GlycoBiology-Motifs","denotations":[{"id":"T2","span":{"begin":41,"end":53},"obj":"http://rdf.glycoinfo.org/glycan/G00053MO"},{"id":"T3","span":{"begin":41,"end":55},"obj":"http://rdf.glycoinfo.org/glycan/G00054MO"},{"id":"T4","span":{"begin":48,"end":53},"obj":"http://rdf.glycoinfo.org/glycan/G00047MO"},{"id":"T5","span":{"begin":48,"end":55},"obj":"http://rdf.glycoinfo.org/glycan/G00051MO"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlycoBiology-Epitope
{"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T1","span":{"begin":41,"end":53},"obj":"http://www.glycoepitope.jp/epitopes/EP0008"},{"id":"PD-GlycoEpitope-B_T2","span":{"begin":41,"end":55},"obj":"http://www.glycoepitope.jp/epitopes/EP0012"},{"id":"PD-GlycoEpitope-B_T3","span":{"begin":48,"end":55},"obj":"http://www.glycoepitope.jp/epitopes/EP0011"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":112,"end":123},"obj":"http://purl.obolibrary.org/obo/UBERON_0001986"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
mondo_disease
{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":136,"end":148},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
Glycan-GlyCosmos
{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":41,"end":55},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G00054MO"},{"id":"A3","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos-GlycoEpitope
{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":41,"end":55},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0012"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos15-MONDO
{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":136,"end":148},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos15-CL
{"project":"GlyCosmos15-CL","denotations":[{"id":"T3","span":{"begin":97,"end":108},"obj":"Cell"}],"attributes":[{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0000542"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos15-UBERON
{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T3","span":{"begin":97,"end":108},"obj":"Body_part"},{"id":"T4","span":{"begin":112,"end":123},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0000542"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001986"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":149},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":149},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos15-Sentences
{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T3","span":{"begin":0,"end":149},"obj":"Sentence"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos15-Glycan
{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":41,"end":55},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G00054MO"},{"id":"A3","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
GlyCosmos15-GlycoEpitope
{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":41,"end":55},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0012"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
Anatomy-UBERON
{"project":"Anatomy-UBERON","denotations":[{"id":"T3","span":{"begin":97,"end":108},"obj":"Body_part"},{"id":"T4","span":{"begin":112,"end":123},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0000542"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001986"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}
CL-cell
{"project":"CL-cell","denotations":[{"id":"T3","span":{"begin":97,"end":108},"obj":"Cell"}],"attributes":[{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0000542"}],"text":"We have shown that synthetic multivalent sialyl Lewis x glycans inhibit strongly the adhesion of lymphocytes to endothelium at sites of inflammation."}